72 related articles for article (PubMed ID: 15948216)
1. A novel apoptosis-inducing anti-PSGL-1 antibody for T cell-mediated diseases.
Huang CC; Lu YF; Wen SN; Hsieh WC; Lin YC; Liu MR; Chiang E; Chang CN; Lin RH
Eur J Immunol; 2005 Jul; 35(7):2239-49. PubMed ID: 15948216
[TBL] [Abstract][Full Text] [Related]
2. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo soluble fas ligand treatment of donor cells to selectively reduce murine acute graft versus host disease.
Georgantas RW; Bohana-Kashtan O; Civin CI
Transplantation; 2006 Aug; 82(4):471-8. PubMed ID: 16926590
[TBL] [Abstract][Full Text] [Related]
4. T-cell P/E-selectin ligand alpha(1,3)fucosylation is not required for graft-vs-host disease induction.
Eom HS; Rubio MT; Means TK; Luster AD; Sykes M
Exp Hematol; 2005 Dec; 33(12):1564-73. PubMed ID: 16338500
[TBL] [Abstract][Full Text] [Related]
5. FTY720 enhances the activation-induced apoptosis of donor T cells and modulates graft-versus-host disease.
Hashimoto D; Asakura S; Matsuoka K; Sakoda Y; Koyama M; Aoyama K; Tanimoto M; Teshima T
Eur J Immunol; 2007 Jan; 37(1):271-81. PubMed ID: 17154260
[TBL] [Abstract][Full Text] [Related]
6. Treatment of collagen-induced arthritis with an anti-osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cells.
Fan K; Dai J; Wang H; Wei H; Cao Z; Hou S; Qian W; Wang H; Li B; Zhao J; Xu H; Yang C; Guo Y
Arthritis Rheum; 2008 Jul; 58(7):2041-52. PubMed ID: 18576331
[TBL] [Abstract][Full Text] [Related]
7. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.
Li J; Davis J; Bracht M; Carton J; Armstrong J; Gao W; Scallon B; Fung R; Emmell E; Zimmerman M; Griswold DE; Li L
Int Immunopharmacol; 2006 Jun; 6(6):880-91. PubMed ID: 16644473
[TBL] [Abstract][Full Text] [Related]
8. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.
Kim W; Kim J; Jung D; Kim H; Choi HJ; Cho HR; Kwon B
Biol Blood Marrow Transplant; 2009 Mar; 15(3):306-14. PubMed ID: 19203721
[TBL] [Abstract][Full Text] [Related]
9. The effect of anti-gp39 treatment on the intestinal manifestations of acute murine graft-versus-host disease.
Stüber E; von Freier A; Fölsch UR
Clin Immunol; 1999 Mar; 90(3):334-9. PubMed ID: 10075862
[TBL] [Abstract][Full Text] [Related]
10. Antibody-mediated signaling through PD-1 costimulates T cells and enhances CD28-dependent proliferation.
del Rio ML; Penuelas-Rivas G; Dominguez-Perles R; Ramirez P; Parrilla P; Rodriguez-Barbosa JI
Eur J Immunol; 2005 Dec; 35(12):3545-60. PubMed ID: 16285013
[TBL] [Abstract][Full Text] [Related]
11. Cross-linking of P-selectin glycoprotein ligand-1 induces death of activated T cells.
Chen SC; Huang CC; Chien CL; Jeng CJ; Su HT; Chiang E; Liu MR; Wu CH; Chang CN; Lin RH
Blood; 2004 Nov; 104(10):3233-42. PubMed ID: 15198951
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effect of novel anti-human Fas antibody HFE7a on graft-versus-host disease model.
Kuwahara H; Tani Y; Ogawa Y; Takaichi Y; Shiraishi A; Ohtsuki M
Clin Immunol; 2001 Jun; 99(3):340-6. PubMed ID: 11358429
[TBL] [Abstract][Full Text] [Related]
13. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
[TBL] [Abstract][Full Text] [Related]
14. Targeting gastrin-releasing peptide receptors on small cell lung cancer cells with a bispecific molecule that activates polyclonal T lymphocytes.
Zhou J; Chen J; Zhong R; Mokotoff M; Shultz LD; Ball ED
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2224-31. PubMed ID: 16609038
[TBL] [Abstract][Full Text] [Related]
15. Peptide-activated double-negative T cells can prevent autoimmune type-1 diabetes development.
Ford MS; Chen W; Wong S; Li C; Vanama R; Elford AR; Asa SL; Ohashi PS; Zhang L
Eur J Immunol; 2007 Aug; 37(8):2234-41. PubMed ID: 17578845
[TBL] [Abstract][Full Text] [Related]
16. Galectin-2 suppresses contact allergy by inducing apoptosis in activated CD8+ T cells.
Loser K; Sturm A; Voskort M; Kupas V; Balkow S; Auriemma M; Sternemann C; Dignass AU; Luger TA; Beissert S
J Immunol; 2009 May; 182(9):5419-29. PubMed ID: 19380789
[TBL] [Abstract][Full Text] [Related]
17. PD-1-PD-L1 pathway is involved in suppressing alloreactivity of heart infiltrating t cells during murine gvhd across minor histocompatibility antigen barriers.
Schilbach K; Schick J; Wehrmann M; Wollny G; Simon P; Schlegel PG; Eyrich M
Transplantation; 2007 Jul; 84(2):214-22. PubMed ID: 17667813
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses.
Kitazawa Y; Fujino M; Wang Q; Kimura H; Azuma M; Kubo M; Abe R; Li XK
Transplantation; 2007 Mar; 83(6):774-82. PubMed ID: 17414712
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of acute graft-versus-host disease by NKG2A engagement on donor T cells.
Kawamura H; Yagita H; Nisizawa T; Izumi N; Miyaji C; Vance RE; Raulet DH; Okumura K; Abo T
Eur J Immunol; 2005 Aug; 35(8):2358-66. PubMed ID: 15997467
[TBL] [Abstract][Full Text] [Related]
20. Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes.
Shieh SJ; Chou FC; Yu PN; Lin WC; Chang DM; Roffler SR; Sytwu HK
J Immunol; 2009 Aug; 183(4):2277-85. PubMed ID: 19635924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]